Clinilabs' CNS division provides a wide range of clinical development services. Clinilabs' resident scientists work with industry key opinion leaders (KOLs) to design and implement studies at all phases of development. Early-phase PK, PD, BA, BE, and interaction studies, as well as Phase II and Phase III pivotal studies, are conducted at the Company's state-of-the-art, 24,400 sq. ft. site in midtown Manhattan. This site is regarded as a center of excellence for research in the areas of sleep, psychiatry, and neurology, and the staff is experienced with a wide variety of assessments of mood, cognition, psychomotor functioning, neuropsychological functioning, EEG and EMG.
|
